PN-355

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePN-355
Drug Alias NameAndroVirPN-355
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionProtein-tyrosine kinases inhibitors
TargetsProtein-tyrosine kinases
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesParacelsian
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesParacelsian
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A